Susquehanna International Group
SUPN icon

Susquehanna International Group’s Supernus Pharmaceuticals SUPN Stock Holding History

Susquehanna International Group’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.11M Sell
40,750
-1,234
-3% -$62.8K ﹤0.01% 6062
2025
Q4 		$2.09M Buy
41,984
+10,623
+34% +$517K ﹤0.01% 5566
2025
Q3 		$1.5M Sell
31,361
-37,314
-54% -$1.5M ﹤0.01% 6413
2025
Q2 		$2.16M Sell
68,675
-11,578
-14% -$371K ﹤0.01% 5628
2025
Q1 		$2.63M Buy
80,253
+48,963
+156% +$1.74M ﹤0.01% 4934
2024
Q4 		$1.13M Buy
31,290
+11,216
+56% +$395K ﹤0.01% 6645
2024
Q3 		$626K Buy
20,074
+7,672
+62% +$239K ﹤0.01% 7936
2024
Q2 		$332K Buy
12,402
+6,037
+95% +$175K ﹤0.01% 9215
2024
Q1 		$217K Sell
6,365
-9,863
-61% -$294K ﹤0.01% 10437
2023
Q4 		$470K Sell
16,228
-20,549
-56% -$545K ﹤0.01% 8827
2023
Q3 		$1.01M Sell
36,777
-9,896
-21% -$301K ﹤0.01% 6602
2023
Q2 		$1.4M Buy
46,673
+1,137
+2% +$39.8K ﹤0.01% 5913
2023
Q1 		$1.65M Buy
+45,536
New +$1.75M ﹤0.01% 5564
2022
Q4 		– Sell
-16,743
Closed -$582K – 13626
2022
Q3 		$567K Buy
+16,743
New +$545K ﹤0.01% 8157
2022
Q1 		– Sell
-28,220
Closed -$865K – 13943
2021
Q4 		$823K Buy
28,220
+9,452
+50% +$287K ﹤0.01% 7809
2021
Q3 		$501K Buy
18,768
+7,967
+74% +$214K ﹤0.01% 9396
2021
Q2 		$333K Sell
10,801
-36,807
-77% -$1.13M ﹤0.01% 10539
2021
Q1 		$1.25M Buy
47,608
+7,930
+20% +$222K ﹤0.01% 7142
2020
Q4 		$998K Buy
39,678
+26,539
+202% +$571K ﹤0.01% 6734
2020
Q3 		$274K Sell
13,139
-15,715
-54% -$357K ﹤0.01% 8898
2020
Q2 		$685K Buy
28,854
+11,971
+71% +$264K ﹤0.01% 6702
2020
Q1 		$304K Sell
16,883
-33,447
-66% -$703K ﹤0.01% 7951
2019
Q4 		$1.19M Sell
50,330
-79,057
-61% -$1.92M ﹤0.01% 5183
2019
Q3 		$3.56M Buy
129,387
+41,037
+46% +$1.22M ﹤0.01% 3227
2019
Q2 		$2.92M Buy
88,350
+70,305
+390% +$2.41M ﹤0.01% 3493
2019
Q1 		$632K Sell
18,045
-100,126
-85% -$3.73M ﹤0.01% 5856
2018
Q4 		$3.93M Buy
118,171
+104,792
+783% +$4.51M ﹤0.01% 2579
2018
Q3 		$674K Sell
13,379
-481
-3% -$23.8K ﹤0.01% 5996
2018
Q2 		$830K Buy
+13,860
New +$718K ﹤0.01% 5742
2018
Q1 		– Sell
-48,191
Closed -$2.01M – 10153
2017
Q4 		$1.92M Sell
48,191
-52,746
-52% -$2.08M ﹤0.01% 3978
2017
Q3 		$4.04M Buy
100,937
+48,086
+91% +$2.08M ﹤0.01% 2791
2017
Q2 		$2.28M Buy
52,851
+10,386
+24% +$370K ﹤0.01% 3682
2017
Q1 		$1.33M Sell
42,465
-135,769
-76% -$3.64M ﹤0.01% 4532
2016
Q4 		$4.5M Buy
178,234
+135,769
+320% +$3.03M ﹤0.01% 2593
2016
Q3 		$1.05M Hold
42,465
– – ﹤0.01% 4718
2016
Q2 		$865K Buy
42,465
+16,896
+66% +$300K ﹤0.01% 5147
2016
Q1 		$390K Buy
25,569
+10,163
+66% +$133K ﹤0.01% 6823
2015
Q4 		$207K Sell
15,406
-17,504
-53% -$271K ﹤0.01% 8367
2015
Q3 		$462K Buy
32,910
+8,349
+34% +$155K ﹤0.01% 7274
2015
Q2 		$417K Sell
24,561
-4,265
-15% -$60.7K ﹤0.01% 7967
2015
Q1 		$349K Sell
28,826
-22,509
-44% -$213K ﹤0.01% 7706
2014
Q4 		$426K Buy
+51,335
New +$431K ﹤0.01% 7533
2014
Q3 		– Sell
-12,153
Closed -$110K – 9937
2014
Q2 		$133K Sell
12,153
-41,052
-77% -$366K ﹤0.01% 9306
2014
Q1 		$476K Sell
53,205
-363,290
-87% -$3.35M ﹤0.01% 6811
2013
Q4 		$3.14M Buy
416,495
+394,401
+1,785% +$2.76M ﹤0.01% 3593
2013
Q3 		$162K Buy
22,094
+12,087
+121% +$81.2K ﹤0.01% 7886
2013
Q2 		$64K Buy
+10,007
New +$58.9K ﹤0.01% 7921

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group's SUPN Position: Q1 2026 in Review

Susquehanna International Group reduced its Supernus Pharmaceuticals (SUPN) stake by 2.9% in Q1 2026, selling an estimated $62.8K and leaving 40,750 shares worth $2.11M. The position accounts for ﹤0.01% of the portfolio, ranked #6062.

Susquehanna International Group first reported a position in SUPN in Q2 2013 and has held it in 47 quarters since. The position peaked at $4.5M in Q4 2016. 327 funds tracked by Wall St. Rank hold SUPN as of Q1 2026.

  • Susquehanna International Group held 40,750 shares of Supernus Pharmaceuticals worth $2.11M as of Q1 2026.
  • Susquehanna International Group sold 1,234 Supernus Pharmaceuticals shares in Q1 2026, an estimated $62.8K.
  • Supernus Pharmaceuticals made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #6062 holding.
  • Susquehanna International Group first reported a position in Supernus Pharmaceuticals in Q2 2013 and has held it in 47 quarters since.
  • Susquehanna International Group's Supernus Pharmaceuticals position peaked at $4.5M in Q4 2016.
  • 327 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.